Clin2
NCT05939453Possibly a fitRecruiting

Bright light therapy for Prader-Willi sleepiness

Prader-Willi SyndromeExcessive Daytime SleepinessHyperphagiaBody WeightMoodBehavior

Part of Brain & nervous system, Genetic & congenital, Hormones & metabolism, Mental health clinical trials.

This trial studies whether daily bright light therapy can reduce sleepiness in people with Prader-Willi syndrome. It may help by improving daytime alertness, but you must meet specific sleepiness, eye-safety, and mental health criteria to join.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
50 people
Ages
6 years to 88 years
Study type
Interventional

Who can take part

  • You have Prader-Willi syndrome confirmed by genetic (DNA) testing
  • Your daytime sleepiness score is 12 or higher on the Epworth Sleepiness Scale
  • You do not have an eye problem that could worsen with bright light (or you don’t need medicines that make you extra sensitive to light)
  • You have not previously had light therapy (LT) before
  • You do not currently have active psychosis or mania

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07685262Recruiting
Bright light therapy for better daytime function in students

This trial tests if morning bright light therapy can help university students feel more awake and function better during the day. You may be eligible if you live in shared student housing and don't have a diagnosed sleep problem.

Hung Hom
NCT06366464Recruiting· Phase 3
Study of a drug for sleepiness in Prader-Willi syndrome

This trial tests a medication called pitolisant to see if it helps reduce excessive daytime sleepiness in people with Prader-Willi syndrome. You or your loved one may be able to join if they have a confirmed diagnosis and a caregiver who can regularly help with study tasks.

Los Angeles, California
NCT07348601Recruiting· Phase 2
Study of CSTI-500 for people with Prader-Willi syndrome

This trial tests an investigational drug called CSTI-500 for people with Prader-Willi syndrome who are in the hyperphagia (constant hunger) phase. It aims to see if the drug can improve behavior and reduce overeating. You and your caregiver will need to visit the clinic regularly and answer questions about symptoms.

Nashville, Tennessee
NCT06698809Recruiting
Treating leftover sleepiness in sleep apnea patients

This study tests if a light therapy device can help reduce daytime sleepiness in people who are already using a CPAP machine for sleep apnea but still feel tired. It involves MRI scans and regular check-ins over two years.

New York, New York
NCT06261528Enrolling by invitation· Phase 1
Light therapy for sleepiness in progressive MS

This trial tests whether a special light therapy can help people with progressive multiple sclerosis who feel sleepy during the day. It aims to improve energy, mood, and sleep patterns.

Dallas, Texas
NCT05917119Recruiting
Bright light therapy for obstructive sleep apnea symptoms

This study tests whether a “bright light” treatment can reduce daytime sleepiness in people with obstructive sleep apnea who are already using CPAP or BiPAP. It may help people feel more awake during the day without changing their sleep apnea device use.

Pittsburgh, Pennsylvania

Hear when a new Prader-Willi Syndrome trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.